Zoledronic side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Zoledronic. Common side effects include osteonecrosis of jaw among females, and osteonecrosis of jaw among males.

The phase IV clinical study is created by eHealthMe based on 26,777 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 12, 2023

26,777 people who take Zoledronic and have side effects are studied.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. Currently, eHealthMe is studying from 26,821 Zoledronic users.

Number of Zoledronic reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Zoledronic?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on zoledronic acid (the active ingredients of Zoledronic) and Zoledronic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Zoledronic:

Zoledronic (26,821 reports)

Common Zoledronic side effects:

Fever: 1,678 reports
Diarrhea: 1,612 reports
Pain: 1,579 reports
Fatigue (feeling of tiredness): 1,526 reports
Nausea and vomiting: 1,507 reports
Weakness: 1,349 reports
Joint pain: 1,290 reports

All Zoledronic side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Docetaxel and Zoledronic drug interaction - 5 seconds ago
Paracetamol and Zoledronic drug interaction - 10 seconds ago
Nitroglycerin and Alprostadil drug interaction - 10 seconds ago
Benadryl and Gastritis - 12 seconds ago
Prograf and Zanaflex drug interaction - 17 seconds ago
Montelukast Sodium and Busulfan drug interaction - 20 seconds ago
Lac-Hydrin and Zovirax drug interaction - 21 seconds ago
Aspirin and Cerebellar Ischaemia - 25 seconds ago
Trazodone Hydrochloride and Euphoric Mood - 27 seconds ago
Paclitaxel and Zoledronic drug interaction - 28 seconds ago